Enhancing Drug Discovery: Integrating High-Content Imaging With Traditional Plate-Based Screening For Comprehensive Analysis And Mechanistic Insights

By Nick Lenhard, Adam McCabe, Clark Driscoll, Gregory Williams, Ph.D.

Traditional plate‑based viability assays provide fast, quantitative readouts but often miss subtle cellular responses that influence therapeutic success. This work demonstrates how incorporating high‑content imaging (HCI) into standard screening workflows can dramatically enhance biological insight without increasing time or cost.

Using fully automated platforms, cytotoxicity assays were augmented with multiplexed imaging stains to simultaneously assess cell viability, morphology, and phenotypic changes. Comparative studies with reference compounds showed that while some agents produced consistent responses across luminescence and imaging readouts, others induced complex morphological effects undetectable by viability data alone. For example, compounds that appeared minimally cytotoxic revealed pronounced multinucleation and mitotic disruption when evaluated through HCI‑based analysis.

Customized image‑analysis workflows enabled quantitative classification of phenotypes such as mitotic catastrophe, providing deeper understanding of compound mechanisms of action. By seamlessly combining plate‑reader data with cellular imaging on a single automation platform, this approach delivers higher‑dimensional insight, reduces false conclusions, and strengthens confidence in early‑stage lead identification.